TipRanks
Denali Therapeutics (DNLI)
NASDAQ:DNLI
US Market
DNLI
Denali Therapeutics
RESEARCH TOOLSreports
Want to see DNLI full AI Analyst Report?

Denali Therapeutics (DNLI) Balance Sheet

887 Followers

Denali Therapeutics Balance Sheet

Denali Therapeutics's total assets for Q2 2026 were $1.16B, a decrease of -8.54% from the previous quarter. DNLI total liabilities were $322.78M for the fiscal quarter, a -5.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 1.14B$ 1.37B$ 1.15B$ 1.46B$ 1.40B
Total Liabilities
$ 131.09M$ 144.50M$ 122.96M$ 417.81M$ 441.87M
Total Equity Gross Minority
$ 1.01B$ 1.23B$ 1.03B$ 1.04B$ 962.29M
Other Metrics
Currency in USD

Denali Therapeutics Debt to Assets